Theravance Biopharma Inc (TBPH) — Cash Flow-to-Debt Ratio
Theravance Biopharma Inc (TBPH) has a Cash Flow-to-Debt Ratio of -0.03x as of December 2025, meaning its operating cash flow of $-6.06 Million could theoretically repay 0% of its total liabilities ($188.85 Million) in one year. See Theravance Biopharma Inc (TBPH) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Theravance Biopharma Inc Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Theravance Biopharma Inc across 15 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Theravance Biopharma Inc.
Annual Cash Flow-to-Debt Ratio for Theravance Biopharma Inc (2011–2025)
Year-by-year debt coverage analysis for Theravance Biopharma Inc. Check Theravance Biopharma Inc (TBPH) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.26x | $238.54 Million | $188.85 Million | ▲ +2055.9% |
| 2024 | -0.06x | $-11.54 Million | $178.62 Million | ▲ +59.6% |
| 2023 | -0.16x | $-27.00 Million | $169.00 Million | ▲ +85.9% |
| 2022 | -1.13x | $-186.99 Million | $165.60 Million | ▼ -287.5% |
| 2021 | -0.29x | $-207.86 Million | $713.39 Million | ▲ +10.1% |
| 2020 | -0.32x | $-250.40 Million | $772.81 Million | ▲ +13.9% |
| 2019 | -0.38x | $-238.20 Million | $632.67 Million | ▼ -104.1% |
| 2018 | -0.18x | $-112.87 Million | $611.82 Million | ▲ +70.1% |
| 2017 | -0.62x | $-201.05 Million | $326.22 Million | ▼ -79.9% |
| 2016 | -0.34x | $-98.99 Million | $289.02 Million | ▲ +88.4% |
| 2015 | -2.96x | $-168.86 Million | $57.05 Million | ▲ +18.9% |
| 2014 | -3.65x | $-175.16 Million | $47.98 Million | ▼ -27.4% |
| 2013 | -2.87x | $-120.96 Million | $42.21 Million | ▲ +45.5% |
| 2012 | -5.25x | $-119.11 Million | $22.67 Million | ▼ -873.2% |
| 2011 | -0.54x | $-83.43 Million | $154.54 Million | — |